The comprehensive analysis of tumor tissue heterogeneity is crucial for determining specific disease states and establishing suitable treatment regimes. Here, we analyze tumor tissue sections from ten patients diagnosed with HER2+ breast cancer. We obtain and analyze multidimensional, genome-wide transcriptomics data to resolve spatial immune cell distribution and identity within the tissue sections. Furthermore, we determine the extent of immune cell infiltration in different regions of the tumor tissue, including invasive cancer regions. We combine cross-sectioning and computational alignment to build threedimensional images of the transcriptional landscape of the tumor and its microenvironment. The three-dimensional data clearly demonstrates the heterogeneous nature of tumor-immune interactions and reveal interpatient differences in immune cell infiltration patterns. Our study shows the potential for an improved stratification and description of the tumor-immune interplay, which is likely to be essential in treatment decisions.
INTRODUCTION
The recent rise in global life expectancy is accompanied by increasing prevalence of agerelated diseases such as cancer 1, 2 . Our current understanding of cancer as well as the efficacy of therapeutic interventions is largely driven by information gained from cancer tissue. A particularly important aspect is related to the identities and distribution of immune cells within tumor tissue [3] [4] [5] . Current standard analyses mainly rely on morphology-based examination of individual tissue sections by pathologists combined with additional insight from immunohistochemistry using antibodies towards known marker proteins 6 . However, a discrepancy between clinical IHC-based and transcriptomics-based analyses has been noted in the classification of HER2+ breast cancers 7 . A number of models for immune response in cancer have been proposed and it is currently under debate whether a high level of lymphocyte infiltration in Basal-like and HER2+ breast cancers is connected to better prognosis in early stage cancers [8] [9] [10] . Two important types of lymphocytes associated with breast cancer are cytotoxic T-cells (CD8+) and helper T-cells (CD4+). Both of these celltypes are present at low amounts in non-malignant breast tissue but show large variation in malignant breast cancer tissue 11 . The infiltrating lymphocytes can be present in the stroma adjacent to the tumor area or directly infiltrate the tumor area and interact with the cancer cells, i.e. tumor infiltrating T-cells. The presence of tumor infiltrating CD8+ T-cells facilitates anti-tumor immunity and is thus correlated with better overall patient survival [12] [13] [14] . In contrast, the presence of intra-tumor CD4+ T-cells is negatively related to patient outcome 15 . The dense concentration of tumor-associated macrophages has also been found to correlate with negative overall survival and the occurrence of metastases [16] [17] [18] . Several additional types of immune cells have been detected in breast cancer tissue, but their exact functions in cancer development remain unknown 19 . The composition and function of tumor infiltrating immune cells can directly influence the efficacy of certain therapeutic approaches. Recently, cancer immunotherapy, in which immune cells are stimulated to target the tumor, has begun to show promising results 20, 21 . In such cases, comprehensive cancer-immune cell interaction analyses prior to specific activation might prove pivotal to therapeutic success.
The standard methods for describing the immune cell composition of tumor tissue depend on predetermined histological and molecular immune markers and are limited regarding multiplexing applications. They also heavily rely on microscopic assessments by trained pathologists, but traditionally lack three-dimensional resolution. To overcome these obstacles, we designed a workflow that leverages computational analysis of Spatial Transcriptomics data for the functional and immune cell type analysis of HER2+ breast cancer tissue samples. The computational approaches used in previous reports 22, 23 , which are solely based on gene expression values, are more suitable for tissue samples with clearly defined molecular structures. However, tumor samples are usually highly complex in terms of cell mixture and distribution; therefore, other approaches are needed to reliably describe the molecular properties of such samples. In the presented study, we use an approach called Latent Dirchlet Allocation (LDA) 24 . The method was originally developed to describe the distribution of topics within a text. Any given sample has a specific proportion of each topic, allowing each sample to contain several topics simultaneously.
Recently, this method has been successfully applied to biological experiments, for example, in the analysis of RNA-seq data 25, 26 . Since each spatial spot contains a mixture of several different cell-types, this method is well suited for Spatial Transcriptomics 22 data and can be exploited to identify underlying gene expression structures. Spatial spots with similar proportions of the topics (herein called gene expression topics) are considered to contain similar cell mixtures and are pooled to gain more depth in the data. Here, we show that this approach can be used to classify tissue regions based on function rather than morphology. By combining Spatial Transcriptomics with robust computational tools, we can now present immune cell distribution with richer spatial information. The further integration of cross-sectioning with computational alignment enables us to generate 3Dimages of global expression patterns and immune score distributions throughout the samples.
RESULTS
Three tissue sections were collected from each of the ten patients (A-J) diagnosed with HER2+ breast cancer included in this study (Supplementary Table 1 ). The collected sections were then subjected to Spatial Transcriptomics 22, 23, 27, 28 using circular spatial spots with a diameter of 100µm. Each tumor was carefully examined by a trained pathologist, who annotated the different morphological regions in each tissue section. These annotations either served as a reference for subsequent unsupervised analysis or were used directly to pick spatial spots from regions of interest. During unsupervised analysis, we established biological functions and determined immune cell composition at the transcriptional level by using LDA to identify underlying structures of gene expression patterns. The proportions of gene expression topics were further used for hierarchical clustering, the object of which was to organize spatial spots with similar gene expression patterns into distinct clusters. Expression data from spatial spots within each cluster were further collapsed to increase gene detection. Next, pathway analysis 29 was carried out between clusters in order to detect spatial correlation between different regions across the tissue. We then applied xCell 30 , a method for describing immune cell composition, to gain spatial information about the complex tumor-immune cell landscape by determining the abundance of sixteen different immune cell-types. The method overview is presented in Fig. 1a .
The morphological examination of tumor sections revealed inter-and intra-patient tissue heterogeneity. Tumors from all ten patients had invasive components, but only tumors from four patients (A, G, H and J) contained regions annotated as ductal carcinoma in situ (DCIS). Tumors from six of the patients (E, F, G, H, I and J) contained regions with a high abundance of immune cells. Other major tissue types identified included fat tissue, fibrous tissue and normal glands ( Fig. 1b, Supplementary Fig. 1a ). To study gene expression differences and similarities between tumors, we generated triplicate transcriptomics data sets (in silico bulk) for each patient. Dimensionality reduction by Principal Component Analysis (PCA) revealed several separate groups of patients, indicating large interpatient variation ( Supplementary Fig. 1b ).
To further analyze the Spatial Transcriptomics data, we applied LDA to each patient sample. A number of gene expression topics, each described by a certain set of genes, was used in the analysis (Supplementary Table 2 ). The gene expression sampling was based on the circular spatial spots. We visualized the data in a way that is easy for the human eye to interpret by generating interpolated images of the spatial spot positions, values of gene expression topic proportions and binary images of tissue morphology ( Supplementary Fig.   2 ). We projected the interpolated values across the tissue sections to display the spatial distribution of gene expression topics. A comparison with the pathologists' annotations ( Fig. 1b , Supplementary Fig. 1a ) revealed that certain gene expression topics clearly overlapped with regions described to be stromal, cancer, immune and gland-enriched ( Fig.   1c , Supplementary Fig. 3 ). This finding demonstrates that applying LDA to Spatial Transcriptomics data can provide valuable information about the tumor microenvironment.
Next, we clustered spatial spots based on the proportions of gene expression topics ( Fig.   2a , Supplementary Fig. 4 ). To validate the clustering, we also visualized the proportions of gene expression topics in t-SNE space ( Fig. 2b, Supplementary Fig. 5 ) and overlaid them with the tissue morphology ( Fig. 2c , Supplementary Fig. 6a ). The separation of spatial spots in t-SNE space corresponded well to the gene expression topic clusters, while the spatial cluster distribution over the tumor section closely resembled the manual annotation.
Taken together, these results demonstrate that clustering spatial spots based on gene expression topic proportions is a reliable approach for characterizing the tumor microenvironment in samples. To analyze variation across the triplicate data sets of each patient, we calculated the proportions of spatial spots assigned to each cluster in each triplicate. Most clusters showed similar distributions across the three data sets with the small variations between sections most likely representing molecular variation in different parts of the tumor ( Supplementary Fig. 6b ). Interestingly, the clustering revealed more details about the tissue than the manual annotation. As an example, a large region annotated as ductal carcinoma in situ (DCIS) in patient H also contained spatial spots that were assigned to cluster H2, which corresponds to a region dense in invasive tumor cells, suggesting that this region has morphological properties of DCIS but molecular properties of invasive cancer ( Fig. 2d ). To further validate our clustering approach, we carried out differential gene expression analysis between each hierarchical cluster ( Fig. 2a -c, Supplementary Fig. 4-6 ) and the rest of the tissue. A pathway analysis 29 was then performed on the differentially expressed genes (Supplementary Table 3 ) to identify biological functions for various regions of the tumor sample (Supplementary Table 4 ). In most of the patients, we detected clusters in which the predominant pathways were clearly related to immune response. These clusters mainly overlapped with regions annotated as immune cells, tumor stroma/fibrous tissue and invasive cancer ( Fig. 2e ).
To further explore the data, we calculated spatial immune scores and determined the immune cell composition within each sample. The previously derived clusters served as the input for immune cell analysis with xCell 30 , which requires decent read depth regarding gene detection and counts to work properly. To obtain additional coverage and to overcome the exclusion of genes with low expression, we collapsed spatial spots within each cluster.
This approach enabled us to detect almost six times more unique genes per sample ( Supplementary Fig. 6c ). The immune cell analysis revealed a high total immune score (the sum of several cell-types) for the annotated immune cell areas in a majority of the samples ( Fig. 3a , Supplementary Fig. 7 ). Additionally, in several samples the total immune score overlapped well with the pathway analysis results ( Fig. 2e ). This approach also provided the immune cell composition for each of the clusters ( Fig. 3b , Supplementary Fig. 8 ). For most samples, the highest values were detected in the regions annotated as immune cell dense. However, the scores for certain immune cell-types were relatively high even in other regions. For example, in patient H, Th2 (T helper cell 2), class-switched memory B-cells and memory B-cells were detected in the DCIS, tumor stroma, and all stroma regions, respectively (Fig. 3c ). The predominant immune cell type identified in DCIS clusters from four patients (patient A: A13, patient G: G11, patient H: H8, patient J: J1 and J8) was Th2, a finding that suggests a homogeneous immune cell pattern within DCIS tissue ( Fig. 3b , Supplementary Fig. 8 ).
Subsequent analysis focused on the immune cell composition of tumor regions annotated
as invasive cancer across all ten patients. We selected spatial spots from the invasive regions of all tumor sections. A dimensionality reduction by PCA revealed four major groups, with patients A and F clearly separated from each other as well as the other patients.
Patients E and H formed their own group (Fig. 4a ), a finding that was also noted in the "bulk" analysis ( Supplementary Fig. 1b ). Furthermore, we used invasive spatial spots as the input for the immune cell analysis. The patient samples could be categorized into four groups (i-iv) based on immune cell composition ( Fig. 4b ). As was observed in the PCA, patients E and H also clustered together in this analysis, which indicates that the tumors of these two patients share a tumor infiltrating immune cell composition. The invasive cancer regions in samples from these two patients showed substantial immune cell diversity, containing mostly Natural killer cells (NKT), CD8+ Tem (effector memory T-cells), Th1 31 . The presence of these types of tumor infiltrating CD8+ T-cells is correlated with better overall survival [12] [13] [14] . Moreover, NKTs have been shown to be highly cytotoxic to cancer cells and likely contributed to previously observed reductions in tumor cells 32, 33 . The tumor sample from Patient J almost exclusively contained Th2 cells. As these cells are mainly responsible for recruiting and activating other immune cells, it is surprising that only this type of immune cell was detected. This finding might reflect failure to activate or attract other immune cell-types, which could negatively influence the overall survival in patients with similar immune cell composition.
cells (T helper cell 1) and CD4+ naïve T-cells with some presence of Memory B-cells and CD4+ Tcm (central memory T-cells). Th1 cells are derived from activated CD4+ naïve Tcells, and can further activate CD8+ T-cells
Tumor samples from three patients, B, F and I, showed mainly CD8+ Tcm (central memory T-cells) with some presence of Th1 cells. The immune cell pattern in these patients is similar to what was noted for patients E and H, but with less immune cell-type diversity.
Tumor regions annotated as invasive cancer from the remaining four patients, C, G, A and D, showed a general absence of lymphoid cell signatures, indicating lack of immune cell infiltration. Patients with this type of pattern usually have poor overall survival 8, 9 and we observe that patients C and D are the only two deceased among the investigated patients (Supplementary Table 1 ).
Our analyses revealed high two-dimensional spatial variation in both gene expression and immune cell composition, which prompted a three-dimensional investigation of the patient samples. We selected samples from four of the patients and used cross-sectioning to collect six sections from each sample. The tissue image alignment provided a transformation matrix that we applied to the spatial spots and generated interpolated expression images into three-dimensional space ( Supplementary Fig. 9 ). The output is a projection of the tissue in which any gene expression value, gene expression topic proportion or immune cell composition can be visualized. We applied the immune scores to the 3D reconstructed data and visualized the output in stacked images of each section (Fig. 5a ) or by volumebased images (Fig. 5b ). Patient A showed virtually no immune score whilst Patient B had the highest immune score among the four patients, but the high immune score was restricted to a few specific continuous nodes in space. Three of the patients showed variation across the additional dimension provided by this analysis, which demonstrates the importance of expanding the analysis from 2D to 3D. To further explore the 3D-data, we developed a R-shiny app (https://spatialtranscriptomics3d.shinyapps.io/ST3D-Viewer/) where all immune-cells and detected genes can be interactively visualized.
DISCUSSION
Here we investigate tumor heterogeneity in samples from ten patients diagnosed with HER2+ breast cancer in two and three dimensions using spatially resolved transcriptomics.
We used novel methods to cluster the transcriptome wide data according to underlying structures in the form of LDA-based gene expression topics rather than pure gene expression values or morphological characteristics. By collapsing spatial spots within the clustering approach, we detected almost six times more genes than when using single spatial spots as the input for cell type analysis, improving the overall sensitivity of the downstream analysis. In most samples, our analysis revealed a clear overlap between the identified LDA clusters and manually annotated regions.
A key property of Spatial Transcriptomics technology is the possibility to identify and characterize the distribution of immune cells within tumor tissue sections in an unbiased way. Here, we applied spatial cell scoring to reveal areas with a presence of immune cells with the aim to study the immune composition within areas of invasive cancer of particular interest for survival outcome and immune therapy. We observe an array of distinct infiltrating immune cell patterns across the different patients. Although more extensive studies will be required to fully grasp the immune landscape, we observe groups of patients sharing similar immune repertoires in situ as well as patients lacking measurable immune cell infiltration. In the extension of this work it is likely that HER2+ tumors can be described not only by the gene expression profile per se but also by scoring the infiltrating immune cell profiles.
More extensive patient sampling is likely to establish a relationship between the extent of immune cell infiltration and node positivity. An interesting observation is that the two deceased patients belonged to the immune score group that showed a lack of immune cell infiltration in the invasive cancer region. Furthermore, tumors from two of the patients also showed the presence of CD4+ naïve T-cells, which are usually not present in tumor tissue 34 but have earlier been reported in breast cancer samples 35 . Importantly, here we demonstrate that the described methodological approach can be used to dissect many different aspects of the immune-tumor interplay and substantiate whether the lack of immune cell infiltration or type of immune cells in tumor tissue is related to worse prognosis and/or lower overall survival. This is the first attempt, to our knowledge, to present genome-wide RNA-seq data from human tissue in three dimensions. This is achieved by combining cross-sectioning with computational image alignment and data transformation. Our model demonstrated that it is possible to detect and follow immune score changes across all three dimensions, and that the analysis of a single, two-dimensional section would leave out important information regarding immune cell distribution within heterogeneous samples.
The resulting comprehensive view of gene expression in a tissue volume can thus facilitate new understanding of tumors and the surrounding microenvironment and has the potential to challenge current diagnostic practices. By nature, cancers are heterogeneous, and the presented results increase the notion of complexity to a higher degree. Yet, the analysis demonstrates that using a three-dimensional description of the tumor tissue landscape can advance diagnostic procedures and help design personalized treatments from the time of diagnosis.
METHODS
Array production. The array production was described previously 22, 36 . Briefly, the microarrays were generated as a 33x35 matrix with a 200 µm center-to-center distance between 100 µm spatial spots. A total of 1007, unique and spatially barcoded DNA oligonucleotides, were used.
Tissue handling, staining and imaging. These steps were described previously 22 . Shortly, fresh frozen material was sectioned at 16 µm. After placing the tissue on top of the barcoded microarray, the glass slide was warmed at 37 °C for 1 min for tissue attachment and fixated in ~ 4% NBF (neutral buffered formalin) for 10 min at room temperature (RT). The slide was then washed briefly with 1x PBS (phosphate buffered saline). The tissue was dried with isopropanol before staining. The tissue was stained with Mayer's hematoxylin for 4 min, washed in Milli-Q water, incubated in bluing buffer for 2 min, washed in Milli-Q water, and further incubated for 1 min in 1:20 eosin solution in Tris-buffer (pH 6). The tissue sections were dried for 5 min at 37 °C and then mounted with 85% glycerol and a coverslip. Imaging was performed using the Metafer VSlide system at 20x resolution. The images were processed with the VSlide software (v1.0.0). After the imaging was complete, the cover slip and remaining glycerol were removed by dipping the whole slide in Milli-Q water followed by a brief wash in 80% ethanol and warming for 1 min at 37 °C. Permeabilization and cDNA synthesis. Permeabilization and cDNA synthesis were carried out as previously described 22 Tissue removal and cDNA release from surface. Tissue removal, as well as the release of cDNAs from surface was described previously 22 . In brief, beta-Mercaptoethanol was diluted in RNeasy lysis buffer and samples were incubated for 1 h at 56 °C. The wells were washed with 0.1x SSC followed by incubation with proteinase K, diluted in proteinase K digestion buffer, for 1 h at 56 °C. The slides were then washed in 2x SSC + 0.1% SDS, 0.2x SSC followed by 0.1x SSC and dried. The release mix consisted of second strand buffer, dNTPs, BSA and USER enzyme and was carried out for 2 h at 37 °C. After probe release, the 1007 spatial spots containing non-released DNA oligonucleotide fragments were detected by hybridization and imaging, in order to obtain Cy3-images for alignment.
Library preparation and sequencing. The protocol followed the same preparation procedures as described earlier 22 , but were carried out using an automated pipetting system (MBS Magnatrix Workstation), also previously reported 27 Mapping, gene counting and demultiplexing. These steps were carried out in a similar fashion to what has previously been described 22 . The forward read contained the spatial barcode and a semi-randomized UMI sequence (WSNNWSNNV) while the reverse read contained the transcript information and was used for mapping to the reference GRCh38 human genome. Before mapping the reads with STAR 37 , the reverse reads were first quality trimmed based on the Burrows-Wheeler aligner and long homopolymer stretches removed.
HTSeq-count 38 with the setting -intersection-nonempty, was used to count only proteincoding and long non-coding transcripts for each gene, using an Ensembl reference file (v.79). The remaining reads were taken into TagGD demultiplexing 39 using the 18 nucleotides spatial barcode. The demultiplexed reads were then filtered for amplification duplicates using the UMI with a minimal hamming distance of 2. The UMI-filtered counts were used in the analysis. The analysis pipeline (v0.8.5) is available at https://github.com/SpatialTranscriptomicsResearch/st_pipeline.
Analysis of bulk data.
The data from all spatial spots, for each tumor or section, were added up separately. The data were either used of PCA or AIMS 40 to determine subtypes.
LDA and clustering. Replicate datasets from each tissue were merged and a Latent
Dirichlet Allocation (LDA) model for each merged dataset using the R package cellTree 25 .
The numbers of topics for each dataset were chosen based the Bayes factor over the Null model 41 using the "maptpx" method with a maximum number of allowed topics set to 15.
The resulting topic matrices were used as a basis for hierarchical clustering of spatial spots.
Clusters were chosen using the adaptive method Dynamic Tree Cut 42 . Clustered spatial spots were color coded and visualized on a heatmap of topic/spatial spot pairs and overlaid on the tissue images. t-SNE based on topic proportions was computed for each sample with each point colored by its respective cluster identity.
Cell-type enrichment analysis. Each cluster was collapsed into vectors by adding the gene
expression values for each spatial spot within that cluster. Cell-type enrichment was performed for each cluster using the gene signature based method xCell 30 or each tissue sample. xCell scores for cluster/cell-type pairs were visualized as heatmaps. Cluster/celltype pair scores were then extrapolated to the spatial spots within each respective cluster to generate matrices with xCell scores for spatial spot/cell-type pairs.
Visualization of cell distribution and interpolation.
Tissue images in jpeg format were converted to grey scale and point scatters of x, y coordinates were generated by defining points at pixel coordinates with intensity below a threshold of 0.5. The 2D point scatters were transformed from pixel coordinates to array coordinates, thus defined in the same coordinate system as the array spatial spots. Next, a raster was generated across each tissue image and points in the 2D scatter were associated with a grid cell by calculating the minimum Euclidean distance. Spatial spot topic proportions and xCell scores were inspected and re-adjusted if necessary. Each tissue section was multiplied three times and stacked by separating each section with an even distance along the z-axis. xCell scores were generated for clusters spanning the whole 3D volume and the values were interpolated onto the 2D scatters separately. All the stacks from each section and sample were combined and visualized as interactive 3D scatter heatmaps (HTMLwidgets) using the R package plotly 46 . xCell scores were scaled to range between 0 and 1 on the color scale.
DE and pathway analysis of clusters. Filtered gene expression data was normalized as
counts per ten thousand by dividing each spatial spot column by its sum of counts and multiplying by 10,000. Spatial spots grouped by LDA based clusters were normalized using scran 47 . First, each cluster was filtered from spatial spots with 0 value size factors and clusters with less than 40 spatial spots were discarded. The remaining clusters were normalized with the computed size factors. DE analysis was performed using an edgeR workflow 48 . For each cluster, a design matrix was constructed grouping clustered spatial spots and all remaining spatial spots separately. Estimates of common and trended dispersions were computed using the "estimateDisp" function and negative binomial generalized log-linear models were fitted to each design matrix using the "glmFit" function. Likelihood ratio tests were calculated using the "glmLRT" function to obtain differentially expressed genes with a log2-fold change greater than 1 at a significance threshold of p = 0.01.
Analysis of annotated regions. Spatial spots within regions annotated as "mainly invasive
cancer", "carcinoma in situ" and "inflammatory cells" were selected using the Spatial Transcriptomics Research Viewer and exported as expression matrices in tsv-format.
Annotated groups were pooled and subjected to cell-type enrichment with xCell and the results were visualized as heatmaps of xCell scores for cluster/cell-type pairs. The Spatial
Transcriptomics
Research Viewer is available at https://github.com/SpatialTranscriptomicsResearch/st_viewer. Supplementary Fig. 1 Overview of patient samples. (a) Morphological regions were characterized by a pathologist and annotated into six distinct categories: DCIS (orange); invasive cancer (red); immune cells (yellow); normal glands (green); fat tissue (cyan); and fibrous tissue (blue Fig. 2 Schematic representation of the interpolation method. Spatial spot values, e.g. gene expression or proportions of gene expression topics, were overlaid with the HE-stained tissue image. HE-stained tissue images were first converted into gray-scale and then into binary format based on a light intensity threshold. Tissue images were then rasterized to generate a grid of cells into which the binary dots were binned according to the minimum Euclidean distance from each binary dot to the grid cell centers. Spatial spots values were interpolated across the grid and assigned to each grid-cell. The binary dot patterns were colored based on the interpolated values and overlaid on top of the grayscale tissue images. Supplementary Fig. 4 Hierarchical clustering of spatial spots. The clustering was based on proportions of gene expression topics in patient tissue samples and performed using Euclidean distance and Ward's method. Reference bars under the dendrograms indicate cluster identity determined by the unsupervised clustering method. Interesting clusters that clearly overlap with the manual annotations are named. Clusters are sample specific, meaning that the same color does not represent a specific region across different samples. Clusters   A1-J1  A2-J2  A3-J3  A4-J4  A5-J5   A6-J6  A7-J7  A8, C8-J8  A9, C9-J9  A10, D10-J10   A11, D11, F11-J11  A12, D12, G11-I12  A13, I13 A14 A15 Supplementary Fig. 5 Non-linear dimensionality reduction using t-SNE. Data points represents spatial spots and are colored based on cluster identity. The plot was used to verify the clustering. Clusters are sample specific, meaning that the same color does not represent a specific region across different samples. 
